1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening is sponsored by National Cancer Institute (NCI) / NIH. This project aims to optimize and personalize breast cancer screening by advancing AI algorithms. It proposes a more realistic AI-CAD system that mimics a radiologist's approach by comparing current and prior mammograms, incorporating clinical risk factors, and accounting for image configuration variations.
It also focuses on practical implementation for clinical use, ensuring model adaptivity and computational feasibility, and will provide a comprehensive DBT database for training, evaluating, and validating models.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Awardee organization is the University of Connecticut Storrs. This indicates that universities and research institutions are eligible. Confirm the full requirements in the official notice before applying.
Applications for SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening are due July 31, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening is funded by National Cancer Institute (NCI) / NIH. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Connecticut. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) Common Fund. This NOFO solicits applications for the design, development, and preliminary validation of robust frameworks for the application of multimodal-artificial intelligence (AI) models for clinical use.
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health. This NOFO solicits applications for the design, development, and preliminary validation of robust frameworks for the application of multimodal-artificial intelligence (AI) models for clinical use, as part of the PRIMED-AI Program.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article